| __timestamp | Evotec SE | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 12122000 |
| Thursday, January 1, 2015 | 18343000 | 13380000 |
| Friday, January 1, 2016 | 18108000 | 21221000 |
| Sunday, January 1, 2017 | 17614000 | 26887000 |
| Monday, January 1, 2018 | 35619000 | 27863000 |
| Tuesday, January 1, 2019 | 58432000 | 55908000 |
| Wednesday, January 1, 2020 | 63945000 | 59392000 |
| Friday, January 1, 2021 | 72200000 | 69012000 |
| Saturday, January 1, 2022 | 76642000 | 36082000 |
| Sunday, January 1, 2023 | 57519000 | 24537000 |
Data in motion
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Evotec SE and Ligand Pharmaceuticals Incorporated have demonstrated contrasting trends in their R&D investments. From 2014 to 2023, Evotec SE's R&D expenses surged by over 360%, peaking in 2022. In contrast, Ligand Pharmaceuticals saw a more modest increase of around 200%, with a notable decline in 2023. This divergence highlights Evotec's aggressive push towards innovation, while Ligand's recent dip may suggest a strategic pivot or market challenges. As the industry evolves, these spending patterns could significantly impact their competitive positioning and future growth. Understanding these trends provides valuable insights into the strategic priorities of these pharmaceutical giants.
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Research and Development Investment: Merck & Co., Inc. vs Evotec SE
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Evotec SE
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE
R&D Spending Showdown: HUTCHMED (China) Limited vs Evotec SE
Research and Development Investment: Protagonist Therapeutics, Inc. vs Evotec SE
R&D Spending Showdown: Evotec SE vs Xencor, Inc.